Semin Liver Dis 2000; 20(4): 451-464
DOI: 10.1055/s-2000-13155
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Timing of Liver Transplantation

W. Ray Kim, E. Rolland Dickson
  • Mayo Medical School and Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Dezember 2000 (online)

ABSTRACT

Under the current environment of liver transplantation, there are several factors to be considered in the timing of liver transplantation. These include expected patient survival with and without liver transplantation, patient's morbidity and quality of life before and after liver transplantation and overall resource utilization. Statistical models have been developed for patients with chronic liver disease, particularly of cholestatic variety. By applying these models in patients being considered for liver transplantation, a window of optimal timing of liver transplantation may be defined in such way that the survival gain is maximized and perioperative mortality minimized. Likewise, a number of pretransplant morbidity indicators such as Child-Pugh score, UNOS status, and renal insufficiency have been found to have a profound influence on post-transplant morbidity, thus resource utilization. An increasing number of investigators have measured and documented a dramatic improvement in the quality of life of patients before and after liver transplantation. As the waiting time and uncertainty of the outcome of liver transplantation increase, consideration of these factors may be useful for physicians evaluating transplant candidates to make best-informed decisions in the selection of candidates and timing for liver transplantation.

REFERENCES

  • 1 Anonymous. National Institutes of Health Consensus Development Conference Statement: liver transplantation-June 20-23, 1983.  Hepatology . 1984;  4 107S-110S
  • 2 Starzl T E, Demetris A J, Van Thiel D. Liver transplantation (1).  N Eng J Med . 1989;  321 1014-1022
  • 3 Starzl T E, Demetris A J, Van Thiel D. Liver transplantation (2).  N Engl J Med . 1989;  321 1092-1099
  • 4 Evans R W, Manninen D L, Dong F B. An economic analysis of liver transplantation. Costs, insurance coverage, and reimbursement.  Gastroenterol Clin N Am. 1993;  22 451-473
  • 5 Bayliss M S, Gandek B, Bungay K M. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C.  Quality of Life Research . 1998;  7 39-55
  • 6 Bonkovsky H L, Woolley J M. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.  Hepatology . 1999;  29 264-270
  • 7 Younossi Z M, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease.  Gut . 1999;  45 295-300
  • 8 Lucey M R, Brown K A, Everson G T. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases [see comments].  Liver Transpl Surg . 1997;  3 628-637
  • 9 Rossle M, Haag K, Ochs A. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding [see comments].  N Engl J Med . 1994;  330 165-171
  • 10 Andreu M, Sola R, Sitges-Serra A. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites.  Gastroenterology . 1993;  104 1133-1138
  • 11 Kaplan M M. Primary biliary cirrhosis [see comments].  N Engl J Med . 1996;  335 1570-1580
  • 12 Roll J, Boyer J L, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis.  N Engl J Med . 1983;  308 1-7
  • 13 Christensen E, Altman D G, Neuberger J, De Stavola L B, Tygstrup N, Williams R. Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model.  PBC1 and PBC2 trial groups. Gastroenterology . 1993;  105 1865-1876
  • 14 Dickson E G, Fleming TR; Fisher LD; Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making.  Hepatology . 1989;  10 1-7
  • 15 Grambsch P M, Dickson E R, Kaplan M. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability.  Hepatology . 1989;  10 846-850
  • 16 Kim W W, Wiesuer R H, Poterucha J J. Adaptation of the mayo primary biliary cirrhosis natural history model for application in liver transplant candidates.  Liver Transpl . 2000;  6 489-496
  • 17 Markus B H, Dickson E R, Grambsch P M. Efficiency of liver transplantation in patients with primary biliary cirrhosis.  N Engl J Med . 1989;  320 1709-1713
  • 18 Neuberger J, Altman D G, Christensen E, Tygstrup N, Williams R. Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis.  Transplantation . 1986;  41 713-716
  • 19 Kim W R, Wiesner R H, Therneau T M. Optimal timing of liver transplantation for primary biliary cirrhosis.  Hepatology . 1998;  28 33-38
  • 20 Christensen E, Gunson B, Neuberger J. Optimal timing of liver transplantation for patients with primary biliary cirrhosis: use of prognostic modelling.  J Hepatology . 1999;  30 285-292
  • 21 Ricci P, Therneau T M, Malinchoc M. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease.  Hepatology . 1997;  25 672-677
  • 22 Delmonico F L, Jenkins R L, Freeman R. The high-risk liver allograft recipient. Should allocation policy consider outcome?.  Archives of Surgery . 1992;  127 579-584
  • 23 Eghtesad B, Bronsther O, Irish W. Disease gravity and urgency of need as guidelines for liver allocation.  Hepatology . 1994;  20 56S-62S
  • 24 Spanier T B, Klein R D, Nasraway S A. Multiple organ failure after liver transplantation.  Critical Care Medicine . 1995;  23 466-473
  • 25 Muto P, Freeman R B, Haug C E, Lu A, Rohrer R J. Liver transplant candidate stratification systems. Implications for third-party payors and organ allocation.  Transplantation . 1994;  57 306-308
  • 26 Cuervas-Mons V, Millan I, Gavaler J S, Starzl T E, Van Thiel H D. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation.  Hepatology . 1986;  6 922-927
  • 27 Doyle H R, Marino I R, Jabbour N. Early death or retransplantation in adults after orthotopic liver transplantation. Can outcome be predicted?.  Transplantation . 1994;  57 1028-1036
  • 28 Mor E, Jennings L, Gonwa T A. The impact of operative bleeding on outcome in transplantation of the liver.  Surg Gynecol Obstetr . 1993;  176 219-227
  • 29 Baliga P, Merion R M, Turcotte J G. Preoperative risk factor assessment in liver transplantation.  Surgery 1992. 112 704-710 710 discussion-711
  • 30 Ploeg R J, D'Alessandro A M, Knechtle S J. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis.  Transplantation . 1993;  55 807-813
  • 31 Gonwa T A, Klintmalm G B, Levy M. Impact of pretransplant renal function on survival after liver transplantation.  Transplantation . 1995;  59 361-365
  • 32 Kim W R, Therneau T M, Dickson E R, Evans R W. Preoperative predictors of resource utilization in liver transplantation.  Clin Transpl . 1995;  315-322